Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07338370

Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

prospective observational cohort study to explore the relationship between PGE2 metabolite levels and the development of hemodynamically significant PDA in preterm neonates.

Key Details

Gender

All

Age Range

1 Day - 7 Days

Study Type

OBSERVATIONAL

Enrollment

34

Start Date

2026-01

Completion Date

2026-04

Last Updated

2026-01-13

Healthy Volunteers

No

Interventions

DRUG

Ibuprofen (Brufen®)

Group1will receive anti-PGE; Ibuprofen (IBU) (brufen)® syrup will be given for 3 days enterally either orally or via a gastric tube with an initial dose of 10mg/kg/day, followed by 5mg/kg/day for the next 2 days. Group 2 will be observed and follow up echocardiography and PGE2 level will be followed up 3 days after treatment or follow up in both groups.

Locations (1)

Faculty of Medicine, Ain Shams, University

Cairo, Abbasia, Egypt